Dual effects of sodium butyrate on hepatocellular carcinoma cells

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 6235-6242

  Jiang, Wenjun ^a   Guo, Qiya ^a   Wu, Jun ^a   Guo, Bin ^a   Wang, Yingming ^a   Zhao, Shenan ^a   Lou, Huiling ^a   Yu, Xin ^a   Mei, Xinyu ^a   Wu, Chaoqun ^a   Qiao, Shouyi ^a   Wu, Yanhua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma (HCC); Histone deacetylase (HDAC); p21 Cip1; p27 Kip1; Sodium butyrate (NaBu)

Indexed keywords

BUTYRIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; S PHASE KINASE ASSOCIATED PROTEIN 2; BUTYRIC ACID DERIVATIVE; HISTONE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYCLIN DEPENDENT KINASE INHIBITOR 1 GENE; CYCLIN DEPENDENT KINASE INHIBITOR 1B GENE; DRUG MECHANISM; GENE; GENE EXPRESSION; LIVER CELL CARCINOMA; MITOSIS INHIBITION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ACETYLATION; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ACETYLATION; APOPTOSIS; BUTYRATES; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; LIVER NEOPLASMS;

EID: 84863752217     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1443-5     Document Type: Article

References (27)

1. Prasad KN (1980) Butyric acid: a small fatty acid with diverse biological functions. Life Sci 27:1351-1358
2. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55:498-505
3. Archer SY, Meng S, Shei A, Hodin RA (1998) p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95:6791-6796
4. Terao Y, Nishida J, Horiuchi S, Rong F, Ueoka Y, Matsuda T, Kato H, Furugen Y, Yoshida K, Kato K, Wake N (2001) Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells. Int J Cancer 94:257-267
5. Mandal M, Kumar R (1996) Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ 7:311-318
6. Tsutsumi T, Ido A, Nakao K, Hamasaki K, Kato Y, Ohtsuru A, Nakata K, Tamaoki T, Nagataki S (1994) Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells. Gastroenterology 107:499-504
7. Finzer P, Kuntzen C, Soto U, zur Hausen H, Rosl F (2001) Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene 20:4768-4776
8. Chopin V, Toillon RA, Jouy N, Le Bourhis X (2004) P21(WAF1/ CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 23:21-29
9. Hung WC, Chuang LY (1999) Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha. Br J Cancer 80:705-710
10. Augeron C, Laboisse CL (1984) Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44:3961-3969
11. Orchel A, Dzierzewicz Z, Parfiniewicz B, Weglarz L, Wilczok T (2005) Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent. Dig Dis Sci 50:490-498
12. Saito H, Kagawa T, Tada S, Tsunematsu S, Guevara FM, Watanabe T, Morizane T, Tsuchiya M (1992) Effect of dexamethasone, dimethylsulfoxide and sodium butyrate on a human hepatoma cell line PLC/PRF/5. Cancer Biochem Biophys 13: 75-84
13. Saito H, Tada S, Ebinuma H, Tsunematsu S, Kagawa T, Kumagai N, Inagaki Y, Watanabe T, Tsuchimoto K, Morizane T et al (1994) Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer. J Gastroenterol 29:733-739
14. Wakabayashi K, Saito H, Kaneko F, Nakamoto N, Tada S, Hibi T (2005) Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor. Int J Oncol 26:233-239
15. Emanuele S, D'Anneo A, Bellavia G, Vassallo B, Lauricella M, De Blasio A, Vento R, Tesoriere G (2004) Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/ caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. Eur J Cancer 40:1441-1452
16. Ogawa K, Yasumura S, Atarashi Y, Minemura M, Miyazaki T, Iwamoto M, Higuchi K, Watanabe A (2004) Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells. J Hepatol 40:278-284
17. Yamamoto H, Fujimoto J, Okamoto E, Furuyama J, Tamaoki T, Hashimoto-Tamaoki T (1998) Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo. Int J Cancer 76:897-902
18. Saito H, Morizane T, Watanabe T, Kagawa T, Miyaguchi S, Kumagai N, Tsuchiya M (1991) Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T. Int J Cancer 48:291-296
19. Saramaki A, Banwell CM, Campbell MJ, Carlberg C (2006) Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34:543-554
20. Wakabayashi K, Saito H, Ebinuma H, Saito Y, Takagi T, Nakamura M, Umezawa A, Hata J, Ishii H (2000) Bcl-2 related proteins are dramatically induced at the early stage of differentiation in human liver cancer cells by a histone deacetylase inhibitor projecting an anti-apoptotic role during this period. Oncol Rep 7:285-288
21. Saito H, Ebinuma H, Takahashi M, Kaneko F, Wakabayashi K, Nakamura M, Ishii H (1998) Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression. Hepatology 27:1233-1240
22. Sung YH, Song YJ, Lim SW, Chung JY, Lee GM (2004) Effect of sodium butyrate on the production, heterogeneity and biological activity of human thrombopoietin by recombinant Chinese hamster ovary cells. J Biotechnol 112:323-335
23. Chotigeat W, Watanapokasin Y, Mahler S, Gray PP (1994) Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells. Cytotechnology 15:217-221
24. Hendrick V, Winnepenninckx P, Abdelkafi C, Vandeputte O, Cherlet M, Marique T, Renemann G, Loa A, Kretzmer G, Werenne J (2001) Increased productivity of recombinant tissular plasminogen activator (t-PA) by butyrate and shift of temperature: a cell cycle phases analysis. Cytotechnology 36:71-83
25. Field RP (1997) US patent 5,681,718
26. Takimoto R, Kato J, Terui T, Takada K, Kuroiwa G, Wu J, Ohnuma H, Takahari D, Kobune M, Sato Y, Takayama T, Matsunaga T, Niitsu Y (2005) Augmentation of antitumor effects of p53 gene therapy by combination with HDAC inhibitor. Cancer Biol Ther 4:421-428
27. Giermasz A, Makowski M, Kozlowska E, Nowis D, Maj M, Jalili A, Feleszko W, Wojcik C, Dabrowska A, Jakobisiak M, Golab J (2002) Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice. Int J Cancer 97:746-750